Micrographia Bio is a pioneering applied AI company in the field of spatial proteomics for drug discovery.

Micrographia Bio (MGB) has developed a new approach which uses spatial proteomics for stunningly sensitive and high-throughput assessment of the true molecular effects of drug candidates, which allows for the production of the highest quality drug candidates at a fraction of the time and cost.

This approach rests on a primary innovation – a new type of microscopy that observes hundreds of different types of individual proteins inside cells, simultaneously. Combined with an unrivalled expertise in ML & MLOps for microscopy image analysis, MGB has developed the first high-throughput platform for assessing therapeutic mechanisms of actions via spatial proteomic drug discovery.